TRANSMEDICS GROUP INC (NASDAQ:TMDX) – A High-Growth Momentum Stock with Strong Technical Setup

TRANSMEDICS GROUP INC (NASDAQ:TMDX) stands out as a high-growth momentum candidate with a solid technical foundation. The company, specializing in organ transplant technology, has demonstrated strong earnings and revenue growth while presenting a favorable chart pattern for potential breakout traders.

Growth Momentum Highlights

• Earnings Growth: TMDX reported a staggering 500% year-over-year EPS growth (TTM), with recent quarterly EPS growth exceeding 100%.
• Revenue Expansion: Sales grew 64.4% over the past year, with consistent quarterly revenue increases, including a 48.2% rise in the most recent quarter.
• Profit Margin Improvement: Quarterly profit margins expanded from 3.9% two quarters ago to 17.9% in the latest report.
• Analyst Confidence: EPS estimates for the next year have been revised upward by 20.4% over the past three months.

Technical Strength

The stock holds a Technical Rating of 9/10, reflecting:

• Positive short-term and long-term trends
• Strong relative performance against 91% of healthcare equipment peers
• Trading near the upper end of its recent range ($88.51 - $130.41)

Setup Quality (7/10)

• The stock shows reduced volatility with prices consolidating in recent weeks
• A recent pocket pivot signal suggests accumulation
• Clear support zones between $121.31-$123.21 and at $105.77

For traders, the technical report suggests a potential entry above $130.42 with support at $121.30 serving as a logical stop level.

Our High Growth Momentum Breakout Setups Screen identifies similar opportunities daily. For a complete technical assessment, review the full technical report on TMDX.

##Disclaimer
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.